ArticleAmerican journal of respiratory and critical care medicine2020
Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1.
Abstract read
In one paragraph
Article in American journal of respiratory and critical care medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 13% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 23 citations in OpenAlex.
- Diagnostic and management dilemmas in pulmonary hypertension.European respiratory review : an official journal of the European Respiratory Society · 2026Review
- Pulmonary Hypertension in Rare Disease Overlap: Neurofibromatosis Type 1 Meets Sarcoidosis.Cureus · 2025Article
- When the Skin Tells a Pulmonary Story: A Case of Neurofibromatosis Type 1-Associated Pulmonary Hypertension.Cureus · 2025Article
- Pulmonary Arterial Hypertension in Neurofibromatosis Type 1: A Case with a Novel NF1 Gene Mutation.Internal medicine (Tokyo, Japan) · 2025Article
- Definition, classification and diagnosis of pulmonary hypertension.The European respiratory journal · 2024Article
- Pulmonary hypertension associated with lung diseases.The European respiratory journal · 2024Review
- Rare genetic interstitial lung diseases: a pictorial essay.European respiratory review : an official journal of the European Respiratory Society · 2024Review
- Pulmonary Hypertension: A Contemporary Review.American journal of respiratory and critical care medicine · 2023Review
- Pulmonary Hypertension in Chronic Lung Diseases: What Role Do Radiologists Play?Diagnostics (Basel, Switzerland) · 2023Review
- The Elephant Man Meets Pulmonary Hypertension. A Cautionary Tale.American journal of respiratory and critical care medicine · 2020Article
- Epidemiology, Pathogenesis, and Clinical Approach in Group 5 Pulmonary Hypertension.Frontiers in medicine · 2020Review
- Neurofibromatosis Type 1 With Cherubism-like Phenotype, Multiple Osteolytic Bone Lesions of Lower Extremities, and Alagille-syndrome: Case Report With Literature Survey.In vivo (Athens, Greece)Article
- Pulmonary hypertension associated with neurofibromatosis type 2.Pulmonary circulationArticle
Corrections and comments
- Commented on by
Authors and funding
33 authors at 15 institutions in 2 countries.
Etienne-Marie JutantSchool of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.ORCID 0000-0002-1374-1890
Xavier JaïsSchool of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Barbara GirerdSchool of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Laurent SavaleSchool of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Maria-Rosa GhignaINSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies.
Frédéric PerrosSchool of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.ORCID 0000-0001-7730-2427
Xavier MignardSchool of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Mitja JevnikarSchool of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Delphine BourlierService des Maladies Respiratoires, Hôpital Haut-Lévêque CHU Bordeaux Pessac, France.
Grégoire PrevotPneumologie et Maladies Rares, Pôle Voies Respiratoires, Hôpital Larrey, Toulouse, France.
Cécile TromeurService de Pneumologie, Hôpital de la Cavale Blanche, Brest, France.
Fabrice BauerINSERM U1096, Heart Failure Clinic and Pulmonary Hypertension Center, Rouen, France.
Emmanuel BergotService de Pneumologie et Oncologie Thoracique, CHU Côte de Nacre, Caen, France.
Claire DauphinService de Cardiologie et Maladies Vasculaires, Hôpital Gabriel Montpied, Clermont Ferrand, France.
Nicolas FavroltService de Pneumologie et Soins Intensifs Respiratoires, CHU François Mitterrand, Dijon, France.
Julie TracletService de Pneumologie, Hôpital Louis Pradel, Lyon, France.
Thibaud SoumagneService de Pneumologie, Hôpital Minjoz, Besançon, France.
Pascal De GrooteService de Cardiologie, CHU Lille, Lille, France.
Céline ChabanneService de Chirurgie Thoracique, Cardiaque et Vasculaire, Hôpital Pontchaillou, Rennes, France.
Pascal MagroService de Pneumologie, CHU de Tours, Tours, France.
Laurent BertolettiService de Médecine Vasculaire et Thérapeutique, CHU de St-Etienne, St-Etienne, France.
Jean-Pierre GueffetUnité de Soins et de Cardiologie Interventionnelle, Hôpital Privé du Confluent, Nantes, France.
Ari ChaouatCentre Hospitalier Régional Universitaire de Nancy, Département de Pneumologie, Hôpital de Brabois, Vandoeuvre-lès-Nancy, France.
François GoupilService de Pneumologie, CH Le Mans, Le Mans, France.
Pamela MoceriService de Cardiologie, CHU de Nice, Nice, France.
Raphael BorieService de Pneumologie, Hôpital Bichat, AP-HP, Paris, France.
Elie FadelINSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies.
Pierre WolkensteinService de Dermatologie, CHU Mondor, AP-HP, Créteil, France.
Pierre-Yves BrilletService de Radiologie, Hôpital Avicenne, AP-HP, Bobigny, France; and.
Gérald SimonneauSchool of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Olivier SitbonSchool of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.ORCID 0000-0002-1942-1951
Marc HumbertSchool of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.ORCID 0000-0003-0703-2892
David MontaniSchool of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.ORCID 0000-0002-9358-6922
Inserm · FRAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier du Mans · FRCentre Hospitalier Universitaire de Besançon · FRCentre Hospitalier Universitaire de Caen Normandie · FRCentre Hospitalier Universitaire de Nice · FRCentre Hospitalier Universitaire de Tours · FRCHU Dijon Bourgogne · FRHôpital Cardiologique du Haut-Lévêque · FRHôpital Larrey · FRHôpital Louis Pradel · FRHôpital Maison Blanche · FRHôpital Pontchaillou · FRHôpital privé du Confluent · FRUniversité Paris-Est Créteil · FR
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
AdolescentAdultFemaleFranceHumansHypertension, PulmonaryLung NeoplasmsLung TransplantationMaleMiddle AgedNeurofibromatosis 1Neurofibromin 1PhenotypePrognosisYoung AdultNeurofibromin 1interstitial lung diseaseneurofibromatosis type 1outcomespulmonary hypertension
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.